T1	intervention 20 41	Calendula officinalis
T2	condition 59 87	radiation-induced dermatitis
T4	eligibility 369 412	women undergoing breast cancer radiotherapy
T5	total-participants 425 428	271
T6	total-participants 453 455	82
T8	total-participants 757 759	81
T9	intervention-participants 792 794	40
T10	control-participants 810 812	41
T12	iv-bin-percent 938 941	53%
T13	cv-bin-percent 958 961	62%
T3	control 241 268	standard of care (Sorbolene
T16	outcome 1050 1072	complete case analysis
T11	outcome 877 914	radiation-induced dermatitis grade 2+
T7	outcome-Measure 497 561	prevalence of acute radiation-induced dermatitis (RTOG grade 2+)
